Haybaeck J

No ORCID on file · 5 papers in corpus · active 2013-2023

Study types

  • review 2

Condition tags

  • endometriosis 2
  • mesh:D004716 1
  • adenomyosis 1
review 2023
Biomolecules ·doi:10.3390/biom13081253

Ovarian clear cell (OCCC) and endometrioid (EnOC) carcinomas are often subsumed under the umbrella term "endometriosis-associated ovarian cancer" (EAOC), since they frequently arise from ectopic endometrium settled in the ovaries. The phosp…

review 2022
International journal of molecular sciences ·doi:10.3390/ijms23073416

Adenomyosis, endometriosis, endometritis, and typical endometrial hyperplasia are common non-cancerous diseases of the endometrium that afflict many women with life-impacting consequences. The mammalian target of the rapamycin (mTOR) pathwa…

2020
Cancers ·doi:10.3390/cancers12010205

Studies of the mechanistic (mammalian) target of rapamycin inhibitors (mTOR) represent a step towards the targeted treatment of gynecological cancers. It has been shown that women with increased levels of mTOR signaling pathway targets have…

2019
International journal of molecular sciences ·doi:10.3390/ijms20246169

Whilst the role of eukaryotic translation initiation factors (eIFs) has already been investigated in several human cancers, their role in endometrial cancer (EC) is relatively unknown. In the present retrospective study, 279 patients with E…

2013
International journal of molecular sciences ·doi:10.3390/ijms14059536

UnlabelledOvarian carcinoma (OC) is the most lethal gynecological malignancy. Response to platinum-based chemotherapy is poor in some patients and, thus, current research is focusing on new therapy options. The various histological types of…